Skip to main content
. 2009 Jun 16;45(3):191–195. doi: 10.1016/j.jcv.2009.06.005

Table 1.

Prevalence of respiratory viruses identified by the xTAG RVP assay during the novel H1N1 outbreak.

Virus Number (%) Mixed infections
Flu A (UST) novel H1N1 1108 (40.8%) E/R(57), 229E(3), HKU-1(2), hMPV(2), P1(4), P3(4), P4(3), RSV(1)
Flu A H1N1 6 (0.2%) Adeno(1), E/R(1)
Flu A H3N2 151 (5.6%) E/R(6), hMPV(1)
Flu B 5 (0.2%) P3(2)
Entero/Rhino (E/V) 451 (16.6%) Flu A(57), H1N1(6), H3N2(6), P1(5), P2(1) P3(12), P4(5), hMPV(6), Adeno(4)
hMPV 58 (2.1%) E/R(3), RSV(1), H3N2(1)
Parainfluenza 3 77 (2.8%) E/R(12), Flu B(2), RSV(2)
Parainfluenza 1 34 (1.3%) E/R(5)
Parainfluenza 4 18 (0.7%) E/R(2)
Parainfluenza 2 3 (0.1%) E/R(3)
Adenovirus 24 (0.9%) E/R(4), H1N1(1)
Coronaviruses 16 (0.6%) Types: NL63(2), 229E(8), HKU-1(6)
RSV 16 (0.6%) P3(2), hMPV(1)
Negative 870 (32%)

UST, unsubtypeable and presumed novel H1N1; Adeno, adenovirus; coronaviruses 229E, NL63 and HKU-1; E/R, enterovirus/rhinovirus group; hMPV, human metapneumovirus; P1, parainfluenza virus 1; P2, parainfluenza virus 2; P3, parainfluenza virus 2; RSV, respiratory syncytial virus. A total of 2715 samples were tested by xTAG RVP assay. Number (%): number identified as positive for virus (percentage of total specimens). Mixed infections: virus (number detected).